Intervention
UT-15C SR
ClinicalTrials.gov intervention label
Clinical trials
4 shownA Pharmacokinetic Substudy of the TDE-PH-304 ProtocolNCT01934582 · 2013-08-01
COMPLETEDRemodulin® to Oral Treprostinil TransitionNCT01588405 · 2012-04-01
COMPLETEDAddition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®NCT01477333 · 2011-10-01
COMPLETEDEfficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial HypertensionNCT00887978 · 2009-06-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED4
Phase mix
PHASE22
PHASE32
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.